{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"bioRxiv"}],"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T21:18:55Z","timestamp":1768511935959,"version":"3.49.0"},"posted":{"date-parts":[[2024,6,4]]},"group-title":"Immunology","reference-count":35,"publisher":"openRxiv","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2024,6,4]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                <jats:p>\n                  Dysregulation of the bone marrow (BM) niche in multiple myeloma (MM) alters the composition and state of resident immune cells, potentially impeding anti-tumor immunity. One common mechanism of immune inhibition in solid tumors is the induction of exhaustion in tumor-specific T cells. However, the extent of T cell tumor recognition and exhaustion is not well-characterized in MM. As the specific mechanisms of immune evasion are critical for devising effective therapeutic strategies, we deeply profiled the CD8\n                  <jats:sup>+<\/jats:sup>\n                  T cell compartment of newly-diagnosed MM (NDMM) patients for evidence of tumor reactivity and T cell exhaustion. We applied single-cell multi-omic sequencing and antigen-specific mass cytometry to longitudinal BM and peripheral blood (PB) samples taken from timepoints spanning from diagnosis through induction therapy, autologous stem cell transplant (ASCT), and maintenance therapy. We identified an exhausted-like population that lacked several canonical exhaustion markers, was not significantly enriched in NDMM patients, and consisted of small, nonpersistent clones. We also observed an activated population with increased frequency in the PB of NDMM patients exhibiting phenotypic and clonal features consistent with homeostatic, antigen-nonspecific activation. However, there was no evidence of \u201ctumor-experienced\u201d T cells displaying hallmarks of terminal exhaustion and\/or tumor-specific activation\/expansion in NDMM patients at any timepoint.\n                <\/jats:p>","DOI":"10.1101\/2024.06.03.597178","type":"posted-content","created":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T14:00:36Z","timestamp":1717509636000},"source":"Crossref","is-referenced-by-count":0,"title":["Hallmarks of tumor-experienced T cells are absent in multiple myeloma patients from diagnosis through maintenance therapy"],"prefix":"10.64898","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3021-9383","authenticated-orcid":false,"given":"Carolyn","family":"Shasha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9924-167X","authenticated-orcid":false,"given":"David R.","family":"Glass","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ernest","family":"Moelhman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Islas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7604-1333","authenticated-orcid":false,"given":"Gregory L.","family":"Szeto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoling","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle","family":"Wurscher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas F.","family":"Bumol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Troy R.","family":"Torgerson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3812-647X","authenticated-orcid":false,"given":"Philip D.","family":"Greenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0477-1446","authenticated-orcid":false,"given":"Damian J.","family":"Green","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2889-243X","authenticated-orcid":false,"given":"Evan W.","family":"Newell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"54368","reference":[{"key":"2024060614501472000_2024.06.03.597178v1.1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2022.0003"},{"key":"2024060614501472000_2024.06.03.597178v1.2","doi-asserted-by":"crossref","unstructured":"Dolina JS , Van Braeckel-Budimir N , Thomas GD , Salek-Ardakani S. CD8+ T Cell Exhaustion in Cancer. Front. Immunol. 2021;12:.","DOI":"10.3389\/fimmu.2021.715234"},{"issue":"12","key":"2024060614501472000_2024.06.03.597178v1.3","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/s41571-022-00689-z","article-title":"Clinical implications of T cell exhaustion for cancer immunotherapy","volume":"19","year":"2022","journal-title":"Nat Rev Clin Oncol"},{"issue":"2","key":"2024060614501472000_2024.06.03.597178v1.4","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3390\/cancers13020217","article-title":"The Role of Tumor Microenvironment in Multiple Myeloma Development and Progression","volume":"13","year":"2021","journal-title":"Cancers"},{"key":"2024060614501472000_2024.06.03.597178v1.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2019.01.031"},{"issue":"6","key":"2024060614501472000_2024.06.03.597178v1.6","doi-asserted-by":"crossref","first-page":"3072","DOI":"10.1002\/cam4.2113","article-title":"Dissecting intratumoral myeloid cell plasticity by single cell RNA-seq","volume":"8","year":"2019","journal-title":"Cancer Medicine"},{"issue":"7735","key":"2024060614501472000_2024.06.03.597178v1.7","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/s41586-018-0694-x","article-title":"Lineage tracking reveals dynamic relationships of T cells in colorectal cancer","volume":"564","year":"2018","journal-title":"Nature"},{"key":"2024060614501472000_2024.06.03.597178v1.8","doi-asserted-by":"publisher","DOI":"10.1126\/science.abe6474"},{"key":"2024060614501472000_2024.06.03.597178v1.9","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-018-0130-2"},{"issue":"9","key":"2024060614501472000_2024.06.03.597178v1.10","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1038\/s41592-022-01578-0","article-title":"VDJdb in the pandemic era: a compendium of T cell receptors specific for SARS-CoV-2","volume":"19","year":"2022","journal-title":"Nat Methods"},{"issue":"4","key":"2024060614501472000_2024.06.03.597178v1.11","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/s41577-021-00574-3","article-title":"CD8+ T cell differentiation and dysfunction in cancer","volume":"22","year":"2022","journal-title":"Nat Rev Immunol"},{"key":"2024060614501472000_2024.06.03.597178v1.12","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.202491499"},{"issue":"11","key":"2024060614501472000_2024.06.03.597178v1.13","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1158\/2326-6066.CIR-22-0434","article-title":"Immune Phenotypes and Target Antigens of Clonally Expanded Bone Marrow T Cells in Treatment-Na\u00efve Multiple Myeloma","volume":"10","year":"2022","journal-title":"Cancer Immunology Research"},{"key":"2024060614501472000_2024.06.03.597178v1.14","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-10-246660"},{"key":"2024060614501472000_2024.06.03.597178v1.15","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2011.575"},{"key":"2024060614501472000_2024.06.03.597178v1.16","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-01-825265"},{"issue":"94","key":"2024060614501472000_2024.06.03.597178v1.17","doi-asserted-by":"crossref","first-page":"eadg1094","DOI":"10.1126\/sciimmunol.adg1094","article-title":"TIM-3+ CD8 T cells with a terminally exhausted phenotype retain functional capacity in hematological malignancies","volume":"9","year":"2024","journal-title":"Science Immunology"},{"key":"2024060614501472000_2024.06.03.597178v1.18","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20062387"},{"key":"2024060614501472000_2024.06.03.597178v1.19","first-page":"302145","article-title":"Patients with multiple myeloma develop SOX2-specific autoantibodies after allogeneic stem cell transplantation","volume":"2011","year":"2011","journal-title":"Clin Dev Immunol"},{"key":"2024060614501472000_2024.06.03.597178v1.20","doi-asserted-by":"crossref","unstructured":"Garfall AL , Stadtmauer EA , Hwang W-T , et al. Anti-CD19 CAR T cells with high-dose melphalan and autologous stem cell transplantation for refractory multiple myeloma. JCI Insight. 2019;3(8):.","DOI":"10.1172\/jci.insight.127684"},{"issue":"21","key":"2024060614501472000_2024.06.03.597178v1.21","doi-asserted-by":"crossref","first-page":"15674","DOI":"10.3390\/ijms242115674","article-title":"Immunotherapy of Multiple Myeloma: Current Status as Prologue to the Future","volume":"24","year":"2023","journal-title":"International Journal of Molecular Sciences"},{"key":"2024060614501472000_2024.06.03.597178v1.22","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0057-z"},{"key":"2024060614501472000_2024.06.03.597178v1.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2021.10.001"},{"key":"2024060614501472000_2024.06.03.597178v1.24","doi-asserted-by":"publisher","DOI":"10.1038\/nature14011"},{"key":"2024060614501472000_2024.06.03.597178v1.25","doi-asserted-by":"crossref","unstructured":"Bonaventura P , Shekarian T , Alcazer V , et al. Cold Tumors: A Therapeutic Challenge for Immunotherapy. Front. Immunol. 2019;10:.","DOI":"10.3389\/fimmu.2019.00168"},{"key":"2024060614501472000_2024.06.03.597178v1.26","doi-asserted-by":"crossref","unstructured":"Hartmann FJ , Simonds EF , Vivanco N , et al. Scalable Conjugation and Characterization of Immunoglobulins with Stable Mass Isotope Reporters for Single-Cell Mass Cytometry Analysis. Mass Cytometry: Methods and Protocols. 2019;55\u201381.","DOI":"10.1007\/978-1-4939-9454-0_5"},{"key":"2024060614501472000_2024.06.03.597178v1.27","doi-asserted-by":"crossref","unstructured":"Simoni Y , Fehlings M , Newell EW . Multiplex MHC Class I Tetramer Combined with Intranuclear Staining by Mass Cytometry. Mass Cytometry: Methods and Protocols. 2019;147\u2013158.","DOI":"10.1007\/978-1-4939-9454-0_11"},{"key":"2024060614501472000_2024.06.03.597178v1.28","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.2593"},{"issue":"5","key":"2024060614501472000_2024.06.03.597178v1.29","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/cyto.a.22271","article-title":"Normalization of mass cytometry data with bead standards","volume":"83A","year":"2013","journal-title":"Cytometry Part A"},{"issue":"5","key":"2024060614501472000_2024.06.03.597178v1.30","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.cels.2018.02.010","article-title":"Compensation of Signal Spillover in Suspension and Imaging Mass Cytometry","volume":"6","year":"2018","journal-title":"Cell Systems"},{"key":"2024060614501472000_2024.06.03.597178v1.31","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-017-1382-0"},{"issue":"4","key":"2024060614501472000_2024.06.03.597178v1.32","first-page":"281","article-title":"Scrublet: Computational Identification of Cell Doublets in Single-Cell Transcriptomic Data","volume":"8","year":"2019","journal-title":"cels"},{"key":"2024060614501472000_2024.06.03.597178v1.33","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-41695-z"},{"issue":"3","key":"2024060614501472000_2024.06.03.597178v1.34","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/s41592-020-01050-x","article-title":"Joint probabilistic modeling of single-cell multi-omic data with totalVI","volume":"18","year":"2021","journal-title":"Nat Methods"},{"key":"2024060614501472000_2024.06.03.597178v1.35","doi-asserted-by":"publisher","DOI":"10.1038\/s41592-019-0686-2"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1101\/2024.06.03.597178","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T06:30:57Z","timestamp":1768458657000},"score":1,"resource":{"primary":{"URL":"http:\/\/biorxiv.org\/lookup\/doi\/10.1101\/2024.06.03.597178"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,4]]},"references-count":35,"URL":"https:\/\/doi.org\/10.1101\/2024.06.03.597178","relation":{},"subject":[],"published":{"date-parts":[[2024,6,4]]},"subtype":"preprint"}}